9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Immunovia AB (publ) (0G8X.L)

LSE - LSE Delayed price. Currency in SEK

Add to watchlist

1.4000

-0.0680

(-4.63%)

As of 11:13AM BST. Market open.

Loading interactive chart…

PR Newswire
Invitation to Immunovia's Q1 presentation
Immunovia will publish its first quarter 2024 results on April 29, 2024 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com
PR Newswire
Immunovia announces updated financial calendar
Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.
PR Newswire
Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival through early detection, today announces its next-generation pancreatic cancer test achieved both the primary and secondary endpoints in a model-development study.